These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7320607)

  • 1. [Plasma apolipoprotein E levels in hyperlipidemia (author's transl)].
    Yamada N; Murase T; Akanuma Y; Kosaka K
    Nihon Naika Gakkai Zasshi; 1981 Sep; 70(9):1249-53. PubMed ID: 7320607
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of lipid metabolism assessed by the changes in the plasma concentrations of apolipoproteins (author's transl)].
    Koga S
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1239-41. PubMed ID: 7462752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia].
    Boĭko ER; Ovechkin AO; Kaneva AM; Potolitsyna NN; Boĭko SG
    Ter Arkh; 2007; 79(12):51-4. PubMed ID: 18220032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of pravastatin for hyperlipidemia in patients with type 2 diabetes mellitus.
    Tawata M; Miwa I; Tsuchiya K; Ozawa M; Shindo H; Wakasugi M; Onaya T
    Arzneimittelforschung; 1995 Jun; 45(6):704-8. PubMed ID: 7646575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins].
    Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M
    Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
    Ribalta J; La Ville AE; Heras M; Plana N; Masana L
    Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.
    Brouwers MC; Govers-Riemslag J; Schalkwijk CG; van Greevenbroek MM; van der Kallen CJ; Bekers O; van Dieijen-Visser MP; Ten Oever J; Bilderbeek-Beckers MA; de Bruin TW; Ten Cate H; Stehouwer CD
    Thromb Res; 2008; 122(4):466-72. PubMed ID: 18262228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.
    Jia L; Fu M; Tian Y; Xu Y; Gou L; Tian H; Tian L
    Int J Cardiol; 2007 Sep; 120(3):331-7. PubMed ID: 17166608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
    Kaysen GA; Jones H; Joles JA; van Tol A
    Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iso-electric focusing method for the analysis of apolipoprotein E in very-low-density lipoprotein].
    Nakao Y; Kajikawa T; Kushiro H; Kodama J; Nambu S; Yamamura T; Yamamoto A
    Rinsho Byori; 1983 Feb; 31(2):165-73. PubMed ID: 6854996
    [No Abstract]   [Full Text] [Related]  

  • 15. [Levels of blood apolipoproteins A-I and B in persons with normal blood lipids and persons with hyperlipidemia and proven atherosclerosis].
    Choluj B; Votruba T; Klestincová J; Sedlák F; Matyska L; Hrudková M
    Vnitr Lek; 1985 May; 31(5):464-8. PubMed ID: 3927589
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of allergy to dibutylthiourea caused by diver's footgear (author's transl)].
    Foussereau J; Herve-Bazin B; Cavelier C; Certin JF
    Derm Beruf Umwelt; 1982; 30(2):58-9. PubMed ID: 6806056
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia.
    Yamanouchi Y; Takano T; Hamaguchi H; Tokunaga K
    J Hum Genet; 2001; 46(11):633-9. PubMed ID: 11721882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma apolipoprotein E levels in hypertriglyceridemia.
    Yamada N; Murase T; Akanuma Y; Itakura H; Kosaka K
    Horm Metab Res; 1982 Jun; 14(6):303-6. PubMed ID: 7118054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.